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Abstract 
Nature provides a number of mechanisms to encode dynamic information in biomolecules.  
In metazoans, there exist rare chemical modifications that occur through entirely unique 
mechanistic regimes.  One such example occurs in the Hedgehog (Hh) morphogens, proteins 
singular across all domains of life for the nature of their covalent ligation to cholesterol.  The 
isoform- and context-specific efficiency of the ligation reaction has profound impact on the activity 
of Hh morphogens and represents an unexplored aspect of Hh ligand-dependent cancers.  To 
elucidate the chemical mechanism of this modification, we have defined roles of the 
uncharacterized sterol recognition region (SRR) in Hh proteins.  We use a combination of 
sequence conservation, directed mutagenesis, and biochemical assays to specify residues of the 
SRR that are responsible for cellular and biochemical processes in Hh cholesterolysis.  Our 
investigations offer the first functional template of this region, providing opportunities to identify 
parallel reactivity in nature and revealing new mechanisms that can be exploited as tools in 
chemical biology. 
 
Introduction 
The Hedgehog (Hh) morphogens undergo an auto-catalytic modification that cleaves the 
translated protein approximately in half and covalently appends cholesterol to the last residue of 
the N-terminal fragment.1  To date, this intramolecular small molecule transfer activity has been 
observed only in Hh proteins and in no other domains of life.2  Cholesterol modification is 
fundamental to the activity of the Hh morphogen;3,4 mutation of the catalytic residues are lethal, 
and mutations that reduce the efficiency of the reaction give rise to profound congenital disorders 
(Fig. S1A).5,6  This unique modification appears to have co-evolved with cholesterol-sensing 
mechanisms that coordinate Hh signal transduction, chemically linking embryogenesis to 
cholesterol homeostasis.7,8,9 
The initially translated, full-length Hh proteins (typically 350-475 residues in length) consist 
of an N-terminal signaling domain, an internal catalytic domain, and a C-terminal region known 
as the Sterol Recognition Region (SRR, Fig. 1A).10  During post-translational modification, the 
full-length protein is cleaved at the end of the N-terminal signaling domain; concomitantly, the last 
residue of the N-terminus is released as a cholesterol ester.  Independently, the N-terminal 
residue of the Hh morphogen is palmitoylated by dedicated acyltransferase enzyme in the ER.11,12  
A crystal structure of the first 145 residues of D. melanogaster Hh-C provided by Beachy and 
coworkers immediately revealed the basis for proteolytic activity of the protein: an intein splicing 
domain remarkably similar in tertiary structure to those found in bacteria and fungi.13,14  Inteins 
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catalyze intramolecular attack of a cysteine, serine, or threonine side chain on the backbone 
carbonyl of the preceding residue, effecting N-to-S/O acyl transfer and creating a labile (thio)ester 
bond in the protein backbone.  In conventional inteins, a nucleophilic residue in the C-terminus of 
the protein reacts with this (thio)ester in a transesterification reaction, ultimately ligating the two 
exteins.15,16  However, Hh proteins lack catalytic intein residues required for protein re-ligation.  
Instead, the thioester formed during the splicing reaction is intercepted by cholesterol, co-opting 
this mechanism for small molecule adduction. 
As in many other intein-containing proteins, the N-terminus of Hh does not participate in 
the cleavage reaction.10  Thioester formation and cholesteroylation activities inhere solely in the 
intein and SRR regions, respectively.  Accordingly, cholesterol ligation can occur in vitro and in 
cells when the Hh N-terminus is replaced by fluorescent proteins or simply by a His-tag.17,18,19,20  
However, the molecular details of the SRR that facilitate cholesterol transfer remain unknown.  
The SRR, which spans 50-100 residues in different species, bears no significant homology to 
known proteins in any domain of life.  While nematodes possess Hh intein-domain (Hint) 
homologues that likewise lack a C-terminal nucleophilic residue for transesterification, these 
domains do not couple small molecule transfer to splicing activity.2  The structure of the SRR has 
never been established crystallographically, and to date presents an unsolved challenge for high-
resolution analysis.  Moreover, no static conformation can fully capture the dynamic activity of 
these fascinating proteins.  
To define structural requirements for cholesterol transfer by the Hh SRR, we used a 
combination of tools at the interface of chemistry and biology.  We demonstrate that the process 
of Hh cholesterolysis encompasses two main activities: 1) engagement of cholesterol as a 
nucleophile, and 2) cellular localization to cholesterol-containing membranes.  We use sequence 
conservation and structure prediction to reveal a helix-loop-helix arrangement that is broadly 
represented among Hh SRRs.  Guided by this structural analysis, we used site-directed 
mutagenesis of these motifs within human Sonic hedgehog (hSHH) expressed in mammalian 
cells to identify loss of function mutations that abolish Hh autoprocessing.  Biochemical analysis 
of full-length protein purified from mammalian cells enabled us to distinguish conserved 
hydrophobic residues that are essential for cholesterolysis in cells but not in vitro.  Cellular 
localization of a fluorescent SRR fusion protein revealed a novel Golgi targeting motif that may 
bias interaction of full-length hSHH with cellular membranes for cholesterol recruitment. By 
defining the structural requirements and elementary steps in this unconventional modification, this 
work expands our understanding of Nature’s chemical biology toolkit and facilitates rational design 
of tools for small molecule ligation in cells. 
 
Results 
A helix-loop-helix motif is conserved across SRRs 
To identify the residues within the SRR that participate in cholesterol transfer we 
considered the SRR as V366-S462 of the hSHH protein, which begins after the last corresponding 
residue in the crystal structure of the D. melanogaster intein domain.10  Cleavage of the D. 
melanogaster protein at this residue renders the protein soluble in the absence of detergent and 
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eliminates cholesterol ligation during proteolysis.  As protein- and nucleotide-based alignment 
programs show no significant homology between the hSHH SRR and other non-Hh proteins, we 
aligned 710 manually curated, diverse Hh proteins to identify common features across species 
and isoforms (Fig. 1B and S2).21  This alignment revealed two sections of conserved residues 
before and after a long intervening sequence that is unique to a subset of Hh proteins (e.g. hSHH).  
Secondary structure analysis revealed that the conserved segments are predicted to form α-
helices,22 while the glycine-rich intervening segment is predicted to be disordered. 
To guide our hypotheses regarding the residue-level contributions of the SRR to 
cholesterolysis, we used ab initio fragment assembly to generate a 3D structure of the last 100 
residues of hSHH, which encompasses the hSHH SRR (Fig. 1C).23  In line with our secondary 
structure predictions, a lowest energy hSHH SRR structure possesses helices at residues from 
W372-L390 (1st helix) and I432-L447 (2nd helix), which are linked by a disordered loop comprising 
residues A391-G431.  The structure contains a “kink” introduced by proline residue P379 in the 
1st helix, which separates the 1st helix into to angled segments from W372-A378 and P379-L390.24  
Helical wheel analysis of the two regions, revealed that each segment of the helices possess a 
face enriched in hydrophobic residues (Fig. 2D).  This arrangement is characteristic of 
amphipathic peripheral membrane helices;25 further, none of our analyses predict these 
sequences to span the bilayer. 
To gain empirical support for our alignment-based model, we synthesized peptides 
comprising the 1st and 2nd helices and examined their secondary structures by Circular Dichroism 
(CD) spectroscopy (Fig. 1E).  As anticipated, these hydrophobic peptides are insoluble in the 
absence of liposomes.  CD spectra of each helix in multidisperse POPC liposomes clearly 
displayed helical character in both the presence and absence of cholesterol. Grounded by 
conservation analysis and secondary structure analysis, we used this model as a scaffold for 
experimental studies to define residue-level structural elements of the SRR that link intein 
proteolysis to cholesterol transfer. 
 
Conserved SRR residues are required for hSHH cholesterolysis in cells 
As a relatively hindered, hydrophobic nucleophile with a pKa of ~18,26 the cholesterol 
hydroxyl group imposes strict requirements on the residues involved in nucleophilic activation and 
trajectory for attack.  Whereas an intein-SRR unit catalyzes cholesterolysis both in cells and in 
vitro, Hh mutants lacking the SRR undergo proteolysis without attachment of cholesterol.10  These 
observations demonstrate that the SRR is necessary and sufficient for biochemical Hh 
cholesterolysis.  In cells, however, the marked insolubility of cholesterol in aqueous solution (<10 
nM)27 and cellular mechanisms of cholesterol sequestration also require mobilization of 
cholesterol from cellular membranes.28  Accordingly, we hypothesize that conserved helices 
within the SRR fulfill two functions: 1) facilitate biochemical attack by cholesterol, and 2) recruit 
the full-length protein to cholesterol-containing membranes in the cell.    
To assess the propensity of mutant hSHH proteins to undergo cholesterolysis in 
mammalian cells, we overexpressed hSHH and mutants in HEK293T cells.  In this cell type, which 
lacks accessory proteins involved in native secretion of cholesteroylated hSHH, differently 
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processed and/or lipidated forms of the hSHH protein partition into cell lysates or secreted media.  
The cholesteroylated and dually lipidated (cholesteroylated and palmitoylated) N-terminal 
proteins remain membrane-associated and are retained in cell lysates.  By contrast, hSHH 
bearing the palmitate modification alone is secreted into cell media.11,29,30,31,32  Accordingly, we 
used production of cell-associated hSHH-N in lysates (hSHH-NL) as a measure of 
cholesteroylation for a given SRR mutant (Fig. S3). 
We first generated deletion mutants that lacked components of the helix-loop-helix motif 
identified in our protein alignment and biochemical studies (Fig. 2A).  Consistent with previous 
observations, a construct lacking the SRR failed to produce any cell-associated hSHH-N.10  
Specific deletion of the 1st helix, 2nd helix, and loop region demonstrated that hSHH-N was likewise 
absent in lysate of mutants lacking the 1st or 2nd helices.  Strikingly, the ∆loop construct that lacked 
a non-conserved 32 residue connector functioned identically to the wild-type protein.  This result 
defines the 1st and 2nd helices as a minimal required unit, consistent with the absence of this loop 
region in Hh proteins known to undergo Hh cholesterolysis.33 
To more explicitly probe the residues of the SRR that participate in cholesterolysis in cells, 
we performed alanine scanning of both the 1st and 2nd helices (Fig. 2B and 2C).  Mutation of highly 
conserved 1st helix residues H374, F377, and R381 drastically reduced production of cell-
associated hSHH-N.  Interestingly, mutation of the absolutely conserved P379 residue did not 
reduce the proportion of cell-associated hSHH-N relative to WT but lowered the total amount of 
protein in cell lysate, likely due to an effect on biochemical and/or cellular protein stability.  Based 
on our helical wheel analysis (Fig. 1D), we envisioned that the three conserved leucine residues 
on the same face of the 1st helix, L382, L386, and L390 might interact with the lipid tails of the 
membrane.  Consistent with this hypothesis, Monte Carlo simulations of  the interaction between 
the 1st helix peptide and a phospholipid bilayer predict that these three leucines will reside at the 
membrane interior (Fig. 2D).34  While single L382A, L386A, and L390A mutants enabled the 
production of cell-associated hSHH-N, a L382A/L386A/L390A triple mutant drastically reduced 
cell-associated hSHH-N, indicating that a stretch of alanine residues is insufficient to support the 
production of cholesteroylated hSHH-N in cells (Fig. 2E).  Consistent with a model involving 
membrane association, replacement of either of the individual L382 or L386 residues with a 
negatively charged residue (glutamate) abolished production of cell-associated hSHH-N.  An 
L390E mutation showed a significant but attenuated reduction of cell-associated hSHH-N, 
whereas glutamate mutation of L387, which is perpendicular to the hydrophobic leucine surface, 
shows only slight reduction in cell-associated hSHH-N versus wild-type protein.  This model also 
suggests an electrostatic interaction between the basic residues H374 and R381 and 
phospholipid head groups, which may contribute to membrane association.25 
The 2nd helix of the hSHH SRR contains a HWY motif that is largely conserved among 
species and Hh isoforms.  While this motif has been demonstrated to regulate post-cleavage 
trafficking of hSHH-C,35 a contribution to cholesterolysis has not been tested.36  Alanine mutation 
of each residue in this motif drastically reduced production of cell-associated hSHH-N (Fig. 2H).  
In particular, hSHH-N was undetectable in the lysates of cells expressing a Y435A mutant.  We 
envisioned that this conserved tyrosine residue might participate in a hydrogen bond interaction 
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with the C3-OH of cholesterol.  Surprisingly, mutation of this residue to an alternative hydrogen 
bond donor (aspartate) failed to rescue production of cell-associated hSHH-N.   Interestingly, 
mutation to phenylalanine reduced total protein in lysate but restored the fraction of cell-
associated hSHH-N relative to wild-type.  The exclusive recovery of cell-associated hSHH-N by 
an aromatic residue suggests a potential mechanistic contribution of the Y435 𝜋-system to 
cholesterolysis.37  By contrast, the lower overall expression of Y435F suggests that the hydroxyl 
group is essential to biochemical and/or cellular protein stability. 
The segment of the 2nd helix following the HWY motif consists of a number of polar 
residues interspersed with four conserved leucine residues (L438, L439, and L446, and L447).   
Surprisingly, while alanine replacement of the conserved L447 residue significantly decreased 
cell-associated hSHH-N, mutation of the less conserved residues L438, I442, and L446 to alanine 
had an attenuated effect (Fig. 2C).  Alanine scanning of the remaining positions in the 2nd helix 
revealed that substitution of the polar residues S436 and T444 and the hydrogen bond donating 
residue Y440 did not significantly reduce production of hSHH-N in lysates.  Likewise, mutation of 
glutamine residues Q437 and Q441 did not affect levels of cell-associated hSHH-N.  Taken 
together, these studies provide a roadmap of the SRR residues involved in cholesterol transfer 
by Hh proteins in human cells. 
 
A subset of SRR residues are required for hSHH cholesterolysis in vitro 
To distinguish between biochemical and cellular factors that contribute to cholesterolysis, 
we investigated the reactivity of SRR mutants toward cholesterol in vitro.  To do so, we appended 
a Myc-DDK tag to the C-terminus of our hSHH construct (Fig. S4).  Overexpression of tagged 
protein followed by mild lysis and affinity purification with agarose conjugated to an anti-FLAG 
antibody enabled us to isolate active unprocessed hSHH-FL free from N-terminal protein 
generated in cells.  Consistent with previous observations, exposure of this protein to 0.5 mM 
cholesterol and 1 mM DTT resulted in production of cholesteroylated hSHH-N (hSHH-NC), which 
could be distinguished from un-cholesteroylated hSHH-N by apparent molecular weight (Fig. 3A, 
Fig. S5).28,30,31,38,39 
For all mutants, exposure of the purified protein to 50 mM DTT effected production of 
hSHH-N, confirming formation of an active thioester.  While a mutant lacking the catalytic cysteine 
residue (C198A) was unreactive, a construct lacking the entire SRR (E368*, ∆SRR) was 
susceptible to in vitro DTT cleavage but not cholesterolysis (Fig. 3B).  Consistent with our cellular 
assays, neither the ∆1st helix nor the ∆2nd helix mutants were capable of undergoing 
cholesterolysis in vitro.  Interestingly, a ∆2nd helix mutant underwent non-cholesteroylative 
cleavage in the presence of DTT and cholesterol, whereas a ∆1st helix mutant was unreactive 
under these conditions.  This result suggests that an interaction between the 1st helix and 
cholesterol is sufficient to promote cleavage but not cholesterolysis.  As anticipated, a ∆loop 
mutant functioned equivalently to wild-type hSHH. 
We next sought to query the in vitro reactivity of 1st helix SRR mutants that failed to 
produce cell-associated hSHH-N.  All purified mutant proteins were capable of undergoing robust 
cleavage at high (50 mM) but not low concentrations (1 mM) of DTT (Fig. S6).  Consistent with 
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our cellular assays, expression levels of the H374A and R381A mutants were lower than wild-
type hSHH, and protein that was produced did not undergo cholesterolysis.  While an F377A 
mutant expressed high quantities of protein, trace hSHH-N protein that was produced in the 
presence of 1 mM DTT and cholesterol likewise did not exhibit a shift characteristic of 
cholesteroylated hSHH-N.  Strikingly, while neither L382A/L386A/L390A, nor L386E mutants 
were capable of producing cell-associated hSHH-N, both exhibited a migration shift to indicate 
cholesterolysis in vitro.  This observation suggests that the L382/L386/L390 residues act primarily 
to facilitate cellular aspects of cholesterolysis, potentially through an interaction involving this 
hydrophobic face within the 1st helix. 
We then sought to characterize the biochemical contributions of the 2nd helix HWY motif 
to cholesterolysis in vitro.  Purified H433A nor Y435A mutant proteins failed to produce 
cholesteroylated hSHH-N, consistent with their observed lack of this reactivity in cells.   As in 
cells, mutation of the conserved Y435 residue to an alternative aromatic (Y435F) but not an 
aliphatic (Y435A) residue preserved biochemical cholesterolysis.  By contrast, a W434A mutant, 
which was also incapable of producing cell-associated hSHH-N, showed restored reactivity 
toward cholesterolysis in vitro. The unique restoration of cholesterolysis by a W434A mutant 
indicates that this residue contributes predominantly to cellular aspects of hSHH cholesterolysis. 
The observation that specific SRR mutants can undergo cholesteroylation in vitro but not 
in cells implies that hSHH-N cholesteroylation entails separable biochemical and cellular 
processes.  Within our structural model, this analysis points to a cluster of conserved aromatic 
residues that is required for biochemical cholesterol adduction opposite to a hydrophobic face 
that is required for cellular cholesterolysis (Fig. 3C).  Thereby, this functional portrait provides a 
launching point for identification of related motifs in nature and a blueprint for redesign. 
 
The SRR contains a Golgi localization motif 
Due to its fleetingly low (nanomolar) concentrations in aqueous media, essentially all 
cellular cholesterol is sequestered in membranes.  Moreover, specific lipid and protein 
compositions within a given membrane control the fraction of active cholesterol that is available 
to interact with other biomolecules.40,41,42,43  While hSHH-N release has been investigated both 
functionally and biochemically in native hSHH-N secreting cells,44,45 only a handful of studies have 
tracked the intra- and extracellular trajectories of the hSHH-C fragment.28,46  Whether the SRR 
has inherent cellular targeting activity is unknown.  
Because the Hh intein domain itself is soluble, we hypothesized that the SRR might 
localize the full-length hSHH protein to microdomains within the ER and or/other membranes for 
cholesterolysis.  To ascertain preferences for subcellular localization inherent to the SRR, we 
created a fusion protein comprising N-terminal EGFP fused to SRR-encompassing residues 
A365-S462 of hSHH (Fig. 3D).  To survey whether the SRR could bias the localization of the intein 
domain, we also created EGFP-intein(C198A), EGFP-intein(C198A)-SRR fusions.  When EGFP 
alone was expressed from a pCMV6-EGFP construct, it assumed a diffuse cellular distribution 
that included the nucleus.  By contrast, when expressed as a fusion with the hSHH SRR, EGFP 
fluorescence was observed as discrete puncta clustered at the periphery of the nucleus, and 
All rights reserved. No reuse allowed without permission. 
perpetuity.preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in 
The copyright holder for this. http://dx.doi.org/10.1101/2019.12.31.892067doi: bioRxiv preprint first posted online Jan. 1, 2020; 
  7 
nuclear fluorescence was eliminated.   Time course studies revealed that this distribution was 
established immediately upon expression and at various levels of overexpression.  Likewise, 
overexpression of an EGFP-intein-SRR but not an EGFP-intein construct was sufficient to 
establish punctate, extranuclear distribution.  Finally, while deletion of the 1st and 2nd helices in an 
EGFP-SRR construct preserved extranuclear fluorescence, deletion of the 1st helix dramatically 
reduced puncta formation and enhanced cytoplasmic fluorescence, while deletion of the 2nd helix 
attenuated, but did not abolish, wild-type EGFP-SRR distribution.  This observation is consistent 
with a significant role for the 1st helix in subcellular trafficking, and reinforces a hypothesis that 
the 1st helix engages in functional membrane interactions during cellular cholesterolysis. 
To determine which cellular compartments colocalize with EGFP-SRR, we co-expressed 
the EGFP-SRR construct with red fluorescent protein-labeled organelle markers (Fig. 3E).  These 
studies revealed that SRR constructs colocalized extensively with the Golgi, as demonstrated 
using mCherry markers bearing either Golgin or β-galactosyltransferase Golgi-targeting 
sequences (Fig. S6).  Importantly, the EGFP-SRR construct showed no indication of lysosomal 
localization to indicate misfolded or aberrantly processed protein.  Partial colocalization was also 
observed with ER and caveolin markers, whereas no significant colocalization was observed with 
the nucleus, peroxisomes, mitochondria, actin, or the plasma membrane (Fig. S7).  Together 
these studies reveal that the SRR imparts a distinct Golgi localization to fusion proteins.   
 
Discussion 
To elucidate the molecular features of the SRR that ligate cholesterol to Hh proteins, we 
have defined residues that are required for cellular and biochemical Hh cholesterolysis.  We used 
sequence conservation to identify common regions of secondary structure, which revealed a 
helix-loop-helix motif shared by all Hh proteins.  Site-directed mutagenesis provided a blueprint 
of residues essential for Hh cholesterolysis in human cells and established minimal criteria for 
biochemical Hh cholesteroylation.  This cellular and biochemical analysis was coupled to our 
identification of a new motif that induces Golgi localization in living cells. 
Our data suggest possible mechanisms by which the SRR achieves this cholesterol-
protein ligation in cells (Fig. 4).  In one scenario, the SRR may tether the full-length Hh protein to 
cholesterol-rich membranes, enabling direct recruitment of a cholesterol nucleophile to the intein 
active site.  Alternatively, the SRR might itself extract cholesterol from the membrane and shuttle 
it to the reactive site within the intein.  Finally, the SRR could form a hydrophobic conduit with the 
intein domain, and together this unit could orient cholesterol for nucleophilic attack. 
These studies can now provide a chemical basis for a number of SRR mutations that lead 
to developmental disease and can shed light on dysregulated Hh ligand activity in cancer (Fig. 
S1).  We are currently building upon this basis set of functional residues to re-engineer the SRR 
ligase activity for alternative substrates and proteins of interest.  Future studies will investigate 
the contribution of intein-SRR interactions to reaction efficiency to inform construct design.  We 
anticipate that this work will lead to a general means to repurpose Nature’s small molecule ligation 
technology as an invaluable tool in the chemical biology of living systems. 
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Materials and Methods 
Antibodies 
Primary antibodies: Shh Antibody (E-1) (N-terminus), (Santa Cruz Biotechnology, sc-365112), 
Sonic Hedgehog/Shh C-Terminus Antibody (R&D Systems, AF445), Loading control: 
Karyopherin β1 (H-7) (Santa Cruz Biotechnology, sc-137016).  Secondary antibodies: Donkey 
anti-Goat IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 647 (Invitrogen, A-
21447), Donkey anti-Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 488 
(Invitrogen, A-21202). 
Constructs 
Myc-DDK-tagged human Sonic Hedgehog (hSHH) in a pCMV6 vector was obtained from 
Origene (RC222175). For analysis of proteins from cell lysates and media, a stop codon was 
introduced after the last residue of hSHH (S462) to obtain untagged hSHH.  Untagged and Myc-
DDK tagged hSHH constructs were used for site-directed mutagenesis to create the 
corresponding SRR mutants.  Briefly, mutagenesis reactions were performed using overlapping 
or non-overlapping primers as required.  Truncation mutants were generated by inserting stop 
codons via site-directed mutagenesis.  SRR deletion mutants were generated by PCR extension 
of the parent hSHH sequence using phosphorylated reverse primers to exclude specified 
residues, then ligating the resulting PCR product using T4 ligase (NEB, M0318).  To generate 
EGFP and EGFP-hSHH constructs used for microscopy experiments, an EGFP insert 
(Clontech, Addgene vdb2487) followed by the linker sequence (GGGS)2 was cloned into the 
pCMV6 backbone before the corresponding hSHH fragment using Gibson assembly.  All PCR 
reactions were performed using Phusion High Fidelity polymerase (NEB, M0530) in the 
presence of 10% DMSO.  Parent construct was digested with DpnI (NEB, R0176).  The full 
hSHH insert sequence for each mutant was verified by Sanger sequencing. 
Sequence alignment and ab initio structure prediction 
Secondary structure prediction for human hSHH SRR (368-462) was performed using the online 
server JPred4 (http://www.compbio.dundee.ac.uk/jpred).  Three dimensional models for the 
hSHH residues 363-462 were predicted by ab initio modelling using the Robetta online server 
(http://robetta.bakerlab.org).  Helical wheel diagrams for the 1st helix (W372-A378 and P379-
L390) and the 2nd helix (I432-L447) were generated using the Heliquest online server 
(http://heliquest.ipmc.cnrs.fr/).  Hedgehog proteins were identified in the Uniprot repository using 
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the query: name:hedgehog NOT name:skinny NOT name:acyltransferase NOT name:interacting 
NOT name:interfering NOT name:interference NOT name:hhat NOT name:like NOT 
name:receptor NOT name:cysteine NOT name:smoothened NOT name:sufu NOT 
name:tetratricopeptide NOT name:similar NOT name:putative NOT name:patched NOT 
name:domain NOT name:hint NOT name:pyruvate NOT name:amino NOT name:peptidase 
NOT name:quality NOT name:containing NOT name:partial length:[356 TO 518], and then by 
manual inspection.  Protein sequences were aligned using the PROMALS3D algorithm 
(http://prodata.swmed.edu/promals3d) and visualized as a sequence logo generated by the 
WebLogo online server (http://weblogo.threeplusone.com/). 
 
Liposome preparation and CD spectroscopy 
Peptides for residues encompassing the 1st helix (368-391) and 2nd helix (431-449) of the hSHH 
SRR were obtained from Genscript Inc. at >90% purity. Crude soybean phospholipids 
containing L-α-phosphatidylcholine (PC, Sigma-Aldrich, P5638) were used to prepare liposomes 
for CD analysis. Briefly, phospholipids in the presence or absence of cholesterol were dissolved 
in chloroform and dried to a thin layer on the sides of a glass vial using a rotary evaporator.  
Dried lipids were resuspended in CD buffer (specified below) and mixed to homogeneity using a 
vortex to yield a 10 mM PC ± 2 mM cholesterol stock solution.  Unilamellar vesicles were 
prepared by disruption on ice using a tip sonicator, and liposomes were centrifuged at 4400 × g 
for 10 minutes to remove undissolved lipids.  Supernatant containing unilamellar vesicles was 
diluted to 0.5 mg/mL and analyzed by dynamic light scattering (Wyatt DynaPro PlateReader-II) 
to assess size distribution. 
CD spectra were collected on 430 Series Aviv Biomedical Inc. spectrophotometer with a rotating 
sample chamber at 25 ºC using a 0.1 cm path length quartz cuvette.  CD scans were collected 
from 190–250 nm with a 1 nm bandwidth and 10 s averaging at each data point. Stock 
liposomes were diluted to a concentration of 0.5 mM PC ± 0.1 mM cholesterol in CD sample 
buffer.  1st helix peptide: A stock solution of peptide in aqueous 50 mM KF was diluted to 50-100 
uM in liposomes ± cholesterol in 10 mM sodium borate (pH 9.6) and 50 mM KF. 2nd helix 
peptide: A solution of 50-100 uM peptide was prepared directly in liposomes ± cholesterol in 10 
mM sodium phosphate (pH 7.4) and 50 mM KF.  Signal for liposomes-only in the corresponding 
buffer was subtracted from the peptide signal for all measurements. 
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Gel electrophoresis and Western blot analysis 
Samples were loaded on a 4-15% SDS-PAGE gel (Bio-Rad, 5678084) in Tris/Glycine/SDS 
running buffer (Bio-Rad, 1610772), and proteins were resolved at a current of 150 V for 1 h at 
room temperature.  After electrophoresis, proteins were transferred to a 0.2 µM PVDF 
membrane (Bio-Rad, 1704157) using a Bio-Rad Trans-Blot Turbo Transfer System.  
Membranes were incubated with primary antibodies at a 1:1000 dilution in 2% milk in PBST (1× 
PBS and 0.1% Tween-20) for 6-12 h at 4 ºC, washed three times for 5 min each with fresh 
PBST, then incubated with secondary antibodies at room temperature for 1-4 h.  Fluorescence 
signal was collected on Bio-Rad Chemidoc MP Imaging System.  Band intensities were 
quantified using Bio-Rad Image Lab Software v6.0.  Briefly, bands corresponding to full length 
and/or processed hSHH proteins in each lane were identified by the software and visually 
inspected for accuracy, and relative pixel intensities were measured for each band. 
Cell culture 
All hSHH proteins were expressed in adherent HEK-293T cells (ATCC, CRL-3216). Cells were 
cultured in high-glucose DMEM (Gibco, 11965118) containing 10% fetal bovine serum (FBS, 
Gibco, 26140079), 100 U/mL of penicillin-streptomycin (Gibco, 15140163), 1 mM sodium 
pyruvate, and 2 mM L-glutamine.  Cells were seeded at an initial confluence of ~20%, passaged 
every 3-4 days upon reaching 85-90% confluence, and maintained in an atmosphere of 5% CO2 
and 95% humidity at 37 ºC.  Transfection mixtures were prepared in low serum media that 
contained 0.5 % FBS instead of 10% FBS.  Polyethylenimine (PEI, PolyScience, 23996-1) (1 
mg/mL stock) was used as a transfection reagent. 
Analysis of hSHH protein from cells 
HEK-293T cells were seeded in a 12-well plate 24 h before transfection at a density of 200,000 
cells/well.   Upon reaching 80-90% confluence, cells were transfected with 0.75 µg hSHH 
plasmid DNA (untagged) and PEI at a ratio of 3:1 PEI:DNA (w/w), which were pre-incubated for 
30 min in Opti-MEM (Invitrogen, 51985034) and diluted in low serum media.  After media 
replacement, cells were incubated for 42-48 hours.  After rinsing with with 200 µL PBS, 125 µL 
ice-cold lysis buffer (50 mM Tris-HCl (pH 7.4), 250 mM NaCl, 1% IGEPAL CA-630, 1× cOmplete 
EDTA-free Protease Inhibitor Cocktail (Roche, 11836170001) and 1 mM PMSF) was added to 
each well and the plate was incubated at 4 ºC with rocking for 10-15 minutes.  Cell material was 
collected by scraping and transferred to microcentrifuge tubes. Cells were then disrupted using 
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tip a sonicator at 60% amplitude for 14 seconds (2 s ON, 1 s OFF). Cell lysate was heated to 98 
ºC for 5 minutes on a heating block, supplemented with SDS-PAGE sample buffer, boiled for 
additional 5 minutes, and analyzed or stored at -20 ºC. 
To detect secreted hSHH proteins, transfection media was collected before cell lysis and protein 
was precipitated with 30% trichloroacetic acid (final) and pelleted by centrifugation. The pellet 
was washed with ddH2O to remove excess trichloroacetic acid, resuspended in 1× SDS-PAGE 
sample buffer, boiled for 5 min, and analyzed or stored at -20 ºC. 
 
Purification of hSHH-FL 
10 million HEK-293T cells were seeded in a 15 cm dish 24 h before transfection. Upon reaching 
80-90% confluence, cells were transfected with 20 µg hSHH plasmid DNA (Myc-DDK tagged) 
and PEI at a ratio of 3:1 PEI:DNA (w/w), which were pre-incubated for 30 min in Opti-MEM 
(Invitrogen, 51985034) and diluted in low serum media. Cells were incubated for 40-48 hours, 
then dissociated with trypsin (TripLE, Thermo Fisher, 12605036), resuspended in culture media, 
and collected by centrifugation at 750 × g for 5 min at room temperature. Cell pellets were flash 
frozen in liquid nitrogen and purified directly or stored at -80 ºC. 
All protein isolation procedures were performed on ice or at 4 ºC.  To isolate Myc-DDK tagged 
hSHH-FL, the cell pellet from each 15 cm plate was resuspended in 1 mL resuspension buffer 
(2× PBS (pH 7.4) + 5% glycerol + 1% Triton-X100 + 1 mM PMSF + 1× Roche EDTA free 
Complete Protease Inhibitor Cocktail).  Cells were disrupted using a tip sonicator for 20 sec (2 
sec ON and 1 sec OFF), then lysate was solubilized by addition of Fos-Choline-12 (Anatrace, 
F308S) to final concentration of 0.5%.  Lysate was incubated in at 4 ºC for 30 minutes with 
gentle rocking to solubilize membrane-associated proteins, then clarified by centrifugation at 
21,000 × g for 10 minutes at 4 ºC. Supernatant was carefully transferred to a new 
microcentrifuge tube and incubated with 100 µL pre-equilibrated Anti-Flag M2 Affinity Gel 
(Sigma, A2220) at 4 ºC with gentle rocking for 2-3 hours. Unbound proteins were removed by 
centrifugation and the beads were washed twice (4× resin volume, 15 minutes each) with wash 
buffer (2× PBS (pH 7.4) + 5% glycerol) containing 0.1% Fos-Choline-12.  Bound proteins were 
eluted by incubating the resin for 2 hours with 0.15 mg/mL FLAG-peptide in a final volume of 
250 µL wash buffer containing 0.1% Fos-Choline12.  Beads were removed from eluate 
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containing hSHH-FL-Myc-DDK by centrifugation at 10,000 × g and used immediately or flash 
frozen in liquid nitrogen and stored at -80 ºC. 
Analysis of hSHH protein reactivity in vitro 
Isolated hSHH-FL-MycDDK protein was thawed on ice and divided into 30 µL aliquots in a PCR 
strip.  For each experiment, 30 µL of the protein sample was boiled immediately after thawing to 
serve as an input control.  For thiolysis, 1 M DTT was added to a final concentration of 50 mM. 
For cholesterolysis, 1 mM DTT was added from the 50 mM DTT stock, then 50 mM stock 
cholesterol in 2-propanol was added immediately with constant gentle vortexing to avoid 
precipitation of cholesterol, to a final concentration of 0.5 mM.  A 1 mM DTT-only reaction was 
performed similarly without cholesterol. The processing reactions were incubated at room 
temperature for 5 hours with gentle rocking.  Reactions were quenched by heating the samples 
to 98 ºC for 5 min and adding 1× SDS-PAGE sample buffer, then samples were analyzed or 
stored at -20 ºC. 
Fluorescence colocalization studies 
HEK-293T cells were seeded 24 h before transfection at 60,000 cells per well on sterile, acid 
cleared coverslips in a 24-well plate. Upon reaching 80-90% confluence, cells in each well were 
transfected with 0.2 µg GFP-hSHH SRR plasmid DNA and PEI at a ratio of 3:1 PEI:DNA (w/w), 
which was pre-incubated for 30 min in Opti-MEM (Invitrogen, 51985034) and diluted in low 
serum media.  When present, the marker plasmids were included at 0.1 µg/well.  After media 
replacement, cells were incubated for 6-8 hours, then rinsed with 1× PBS and fixed with ice cold 
4% paraformaldehyde for 10 minutes. Coverslips were rinsed three times for 5 minutes each 
with 1× PBS before a final rinse in ddH2O, then mounted on clean glass slides in DAPI-free 
mounting media (Invitrogen, ProLong Diamond Antifade Mountant, P36965).  Mounting media 
was cured in the dark for 8-12 h and coverslips were sealed with nail polish.  Images were 
obtained on a Zeiss 700 confocal microscope using a 63× oil immersion objective. 
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 1 
Main Figure Captions 
 
Figure 1. The SRR is a helix-loop-helix motif. A. The intein domain within the C-terminus of 
full-length Hedgehog (Hh) proteins catalyzes formation of a thioester intermediate in the peptide 
backbone.  The SRR facilitates cholesterol attack on the thioester, cleaving the Hh protein and 
ligating cholesterol to the last residue of the N-terminus.  In a separate process, palmitate is 
attached to the first residue of the N-terminus after cleavage of the signal peptide.  Conventional 
intein numbering is shown; R = palmitoyl.  B. Sequence logo for PROMALS3D alignment (ref. 21) 
of the SRR of 710 manually annotated Hedgehog protein sequences above the corresponding 
sequence of hSHH (SRR, residues 363-462). Heatmap below shows the percent helical character 
predicted by the JNet4 algorithm (ref. 22). C. Model of the SRR of hSHH (residues 363-462), 
created using ab initio Rosetta prediction (ref. 23).  D. Helical wheel diagrams of the 1st and 2nd 
SRR helices from HELIQUEST (ref. 24).  The 1st helix is twisted at P379; axial views of each 
segment are shown.  Residues are colored according to the Kyte Doolittle hydrophobicity scale 
(white = hydrophobic, blue = hyrophilic).  E. Circular dichroism (CD) spectra of peptides 
encompassing the 1st helix (residues 368-391) and 2nd helix (residues 431-449) in liposomes. 
 
Figure 2. Conserved residues in the SRR helices enable cellular hSHH cholesterolysis.  A. 
Left: Schematic of deletion mutants lacking individual SRR secondary structure elements.  Middle: 
Western blot analysis of cell-associated hSHH-N protein (hSHH-NL) produced by SRR deletion 
mutants in overexpressing HEK293T cells.  Right: Plot of relative hSHH-NL production versus 
wild-type protein for each mutant.  B and C. Alanine scanning of the 1st and 2nd helices, 
respectively, showing % hSHH-NL versus wild-type produced by each mutant.   Above: sequence 
logos for the corresponding regions (from Fig. 1B). D. Monte Carlo simulation of 1st helix residues 
W372-L390 in a phospholipid bilayer, showing leucine residues L382, L386, and L389 embedded 
in the membrane (ref. 34). E. Relative hSHH-NL produced by alanine and glutamate mutants of 
the three predicted membrane-embedded (L382, L386, L389A) residues and one surface (L387A) 
residue in the 1st helix of the SRR. F. Relative hSHH-NL produced by alanine, aspartate, and 
phenylalanine mutants of Y435 in the 2nd helix of the SRR.  For A, B, C, E, and F: The ratio of 
pixel intensity of hSHH-NL to hSHH-FL for each mutant was compared to the same ratio for wild-
type protein and expressed as %WT.  A biological replicate for wild-type protein was analyzed in 
each blot.  Symbols represent the mean of n > 3 biological replicates for each mutant ± s.d.  
Mutants that produced < 50% hSHH-NL protein relative to wild-type protein are indicated in red. 
 
Figure 3. Specific SRR residues control biochemical cholesterolysis and cellular 
localization.  A. Wild-type hSHH-FL isolated from HEK293T cells shows no cleavage in 1 mM 
DTT, non-cholesteroylative cleavage with 50 mM DTT, and cholesteroylative cleavage with 1 mM 
DTT + 0.5 mM cholesterol.  Cholesteroylated hSHH-N (hSHH-NC) shows a characteristic 
migration shift relative to non-cholesteroylated hSHH-N, as demonstrated by protein generated 
from a construct expressing  hSHH-N only (hSHH-N*, residues 1-197).  B. Cleavage and/or 
cholesterolysis hSHH mutants by 50 mM DTT or 1 mM DTT + 0.5 mM cholesterol.  For additional 
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blots, see Fig. S5. C. SRR model showing residues required for cholesterol modification both in 
cells and in vitro (violet), in cells but not in vitro (green), and Y435 (blue), which is required both 
in cells and in vitro but can be functionally replaced by phenylalanine.  Helical wheels show the 
facial positions of functional residues; the 1st helix is divided into coaxial segments before and 
after the P379 kink.  C. Confocal microscopy images of HEK293T cells expressing EGFP-SRR 
fusion proteins.  D. Colocalization of EGFP-SRR co-expressed with mCherry-labeled Golgi 
(galactosyltransferase, β4Gal-T1) and lysosome (LAMP-1) organelle markers.  Scale bar = 10 
µM. 
 
Figure 4. Models for SRR-promoted cholesterolysis of Hh proteins.  A. The SRR localizes 
the intein domain to a cholesterol-rich membrane interface, enabling direct access of cholesterol 
to the thioester. B. The SRR extracts membrane cholesterol and delivers it to the thioester within 
the intein domain. C. The SRR interacts with the intein domain to create a hydrophobic conduit, 
enabling cholesterol to access the thioester. 
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